Filing Details
- Accession Number:
- 0001127602-19-028752
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-18 17:03:02
- Reporting Period:
- 2019-09-16
- Accepted Time:
- 2019-09-18 17:03:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc. | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1441876 | Mostafa Ronaghi | 5200 Illumina Way San Diego CA 92122 | Svp & Cto | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-16 | 10,000 | $69.34 | 86,585 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-16 | 400 | $298.25 | 86,185 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-09-16 | 4,133 | $300.12 | 82,052 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-09-16 | 4,664 | $300.89 | 77,388 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-09-16 | 803 | $301.72 | 76,585 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-09-16 | 10,000 | $0.00 | 10,000 | $69.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,000 | 2011-02-28 | 2021-01-31 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 400 shares sold ranging from $298.13 to $298.42 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 4,133 shares sold ranging from $299.41 to $300.40 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 4,664 shares sold ranging from $300.44 to $301.39 per share. Number of shares sold at each separateprice will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 803 shares sold ranging from $301.44 to $302.14 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.